A Cost-Effectiveness Analysis of AcrySof IQ Vivity Intraocular Lens (IOL) from Private Health Fund Perspective in Australia.

Chandra BalaPaul AthanasiovJason HollandMukesh DhariwalAmit GuptaHemant Rathi

Published in: Clinical ophthalmology (Auckland, N.Z.) (2022)

AcrySof IQ Vivity intraocular lens is a highly cost-effective treatment strategy with improved vision-related quality of life outcomes for presbyopic cataract surgery patients.

Keyphrases

cataract surgery
healthcare
health insurance
end stage renal disease
ejection fraction
newly diagnosed
public health
patient reported outcomes
health information
skeletal muscle
climate change
weight loss
human health
health promotion